{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T08:35:22Z","timestamp":1648802122216},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.remn.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T14:32:17Z","timestamp":1493994737000},"page":"304-311","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizaci\u00f3n de los criterios metab\u00f3licos en la valoraci\u00f3n pron\u00f3stica de los pacientes con linfoma. Estudio multic\u00e9ntrico"],"prefix":"10.1016","volume":"36","author":[{"given":"M.","family":"del Puig C\u00f3zar-Santiago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Garc\u00eda-Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moragas-Freixa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soler-Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bassa Massanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"S\u00e1nchez-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sanchez-Jurado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Aguilar-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sanz-Llorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ferrer-Rebolleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2017.03.003_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2017.03.003_bib0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers","volume":"54","author":"Biggi","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.03.003_bib0150","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ejca.2010.12.027","article-title":"Prognostic significance of interim (18)F-FDG PET\/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma","volume":"47","author":"Yang","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.remn.2017.03.003_bib0155","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","article-title":"Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma","volume":"13","author":"Spaepen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remn.2017.03.003_bib0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2017.03.003_bib0165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the First International Workshop on interim-PET-scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2017.03.003_bib0170","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00259-013-2435-6","article-title":"An international confirmatory study of the prognostic value of early PET\/CT in diffuse large B-cell lymphoma: Comparison between Deauville criteria and DeltaSUVmax","volume":"40","author":"Itti","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.03.003_bib0175","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","article-title":"Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis","volume":"48","author":"Lin","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.03.003_bib0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2967\/jnumed.113.130609","article-title":"Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients","volume":"55","author":"Rossi","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.03.003_bib0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/10428194.2013.831848","article-title":"Quantitative and qualitative analysis of metabolic response at interim PET-scan combined with IPI is highly predictive of outcome in diffuse large B-cell lymphoma","volume":"55","author":"Nols","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2017.03.003_bib0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00259-012-2320-8","article-title":"Interim FDG PET\/CT as a prognostic factor in diffuse large B-cell lymphoma","volume":"40","author":"Fuertes","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.03.003_bib0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00277-012-1640-x","article-title":"Interim PET\/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era","volume":"92","author":"Yang","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.remn.2017.03.003_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2010-12-327767","article-title":"SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma","volume":"118","author":"Casasnovas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.remn.2017.03.003_bib0205","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2017.03.003_bib0210","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, Fourth Edition","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.remn.2017.03.003_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10428194.2013.802784","article-title":"Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012","volume":"55","author":"Meignan","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2017.03.003_bib0220","first-page":"148","article-title":"Standardized uptake value for 18F-fluorodeoxyglucose is correlated with a high International Prognostic Index and the presence of extranodal involvement in patients with Diffuse Large B-Cell Lymphoma","volume":"33","author":"Akkas","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remn.2017.03.003_bib0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00259-013-2441-8","article-title":"PET\/CT assessment in follicular lymphoma using standardized criteria: Central review in the PRIMA study","volume":"41","author":"Tychyj-Pinel","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.03.003_bib0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13139-015-0368-7","article-title":"FDG PET\/CT response assessment criteria for patients with Hodgkin's and non-Hodgkin's lymphoma at end of therapy: A multiparametric approach","volume":"50","author":"Metser","year":"2016","journal-title":"Nucl Med Mol Imaging."},{"key":"10.1016\/j.remn.2017.03.003_bib0235","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3109\/10428194.2013.850165","article-title":"Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma","volume":"55","author":"Mylam","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2017.03.003_bib0240","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3109\/10428194.2012.677535","article-title":"Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus","volume":"53","author":"Meignan","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2017.03.003_bib0245","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2967\/jnumed.110.080556","article-title":"Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: Importance of the reference background","volume":"51","author":"Itti","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2017.03.003_bib0250","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00259-014-2973-6","article-title":"FDG PET\/CT imaging as a biomarker in lymphoma","volume":"42","author":"Meignan","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2017.03.003_bib0255","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of Deauville five-point scale","volume":"99","author":"Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.remn.2017.03.003_bib0260","doi-asserted-by":"crossref","first-page":"20140360","DOI":"10.1259\/bjr.20140360","article-title":"Impact of 18F-FDG PET\/CT on the staging and management of follicular lymphoma","volume":"87","author":"Mester","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.remn.2017.03.003_bib0265","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2011.35.0736","article-title":"Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: Analysis of PET-CT in a subset of PRIMA trial participants","volume":"29","author":"Trotman","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2017.03.003_bib0270","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00259-012-2079-y","article-title":"FDG PET\/CT predictive role in follicular lymphoma","volume":"39","author":"Lopci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T03:53:57Z","timestamp":1535860437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16301226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2253654X16301226"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2017.03.003","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizaci\u00f3n de los criterios metab\u00f3licos en la valoraci\u00f3n pron\u00f3stica de los pacientes con linfoma. Estudio multic\u00e9ntrico","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}